In vivo modulation of Nogo-B attenuates neointima formation

Molecular Therapy

Volumn 16, Issue 11, 2008, Pages 1798-1804

  Kritz, Angelika B ^a   Yu, Jun ^b   Wright, Paulette L ^b   Wan, Song ^c   George, Sarah J ^d   Halliday, Crawford ^a   Kang, Ning ^c   Sessa, William C ^b   Baker, Andrew H ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^d BRISTOL ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; BETA GALACTOSIDASE; PROTEIN NOGO; PROTEIN NOGO B; UNCLASSIFIED DRUG;

ADVENTITIA; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTERY GRAFT; ARTERY INJURY; ARTERY INTIMA PROLIFERATION; ARTICLE; C57BL MOUSE; CAROTID ARTERY; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG MECHANISM; FEMORAL ARTERY FLOW; GENE OVEREXPRESSION; GENE THERAPY; IN VIVO STUDY; INTIMA; LOW DRUG DOSE; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SAPHENOUS VEIN; SMOOTH MUSCLE FIBER; SWINE; VASCULAR LESION; VASCULAR SMOOTH MUSCLE; VIRAL GENE DELIVERY SYSTEM;

ADENOVIRIDAE; ANIMALS; CAROTID ARTERIES; CELL PROLIFERATION; CELLS, CULTURED; CHEMOTAXIS; CONSTRICTION, PATHOLOGIC; DISEASE MODELS, ANIMAL; FEMORAL ARTERY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GRAFT OCCLUSION, VASCULAR; HUMANS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE, SMOOTH, VASCULAR; MYELIN PROTEINS; SAPHENOUS VEIN; SWINE; TUNICA INTIMA; TUNICA MEDIA;

MURINAE; SUS;

EID: 54949119932     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2008.188     Document Type: Article

References (32)

1. Ruygrok, PN, Webster, MW, de Valk, V, van Es, GA, Ormiston, JA, Morel, MA et al. (2001). Clinical and angiographic factors associated with asymptomatic restenosis after percutaneous coronary intervention. Circulation 104: 2289-2294.
2. Gordon, PC, Gibson, CM, Cohen, DJ, Carrozza, JP, Kuntz, RE and Baim, DS (1993). Mechanisms of restenosis and redilation within coronary stents - quantitative angiographic assessment. J Am Coll Cardiol 21: 1166-1174.
3. Shah, PJ, Gordon, I, Fuller, J, Seevanayagam, S, Rosalion, A, Tatoulis, J et al. (2003). Factors affecting saphenous vein graft patency: clinical and angiographic study in 1402 symptomatic patients operated on between 1977 and 1999. J Thorac Cardiovasc Surg 126: 1972-1977.
4. Whittemore, A (1990). Current techniques for infrainguinal arterial reconstruction. Jpn J Surg 20: 627-634.
5. Finn, AV, Nakazawa, G, Joner, M, Kolodgie, FD, Mont, EK, Gold, HK et al. (2007). Vascular responses to drug eluting stents: Importance of delayed healing. Arterioscler Thromb Vasc Biol 27: 1500-1510.
6. Josephson, A, Trifunovski, A, Widmer, HR, Widenfalk, J, Olson, L and Spenger, C (2002). Nogo-receptor gene activity: Cellular localization and developmental regulation of mRNA in mice and humans. J Comp Neurol 453: 292-304.
7. Oertle, T, Huber, C, van der Putten, H and Schwab, ME (2003). Genomic structure and functional characterisation of the promoters of human and mouse nogo/rtn4. J Mol Biol 325: 299-323.
8. Kim, JE, Li, S, GrandPre, T, Qiu, D and Strittmatter, SM (2003). Axon regeneration in young adult mice lacking Nogo-A/B. Neuron 38 187-199.
9. Qi, B, Qi, Y, Watari, A, Yoshioka, N, Inoue, H, Minemoto, Y et al. (2003). Pro-apoptotic ASY/Nogo-B protein associates with ASYIP. J Cell Physiol 196: 312-318.
10. Kuang, E, Wan, Q, Li, X, Xu, H, Zou, T and Qi, Y (2006). ER stress triggers apoptosis induced by Nogo-B/ASY overexpression. Exp Cell Res 312: 1983-1988.
11. Acevedo, L, Yu, J, Erdjument-Bromage, H, Miao, RQ, Kim, JE, Fulton, D et al. (2004). A new role for Nogo as a regulator of vascular remodeling. Nat Med 10: 382-388.
12. Paszkowiak, JJ, Maloney, SP, Kudo, FA, Muto, A, Teso, D, Rutland, RC et al. (2007). Evidence supporting changes in Nogo-B levels as a marker of neointimal expansion but not adaptive arterial remodeling. Vascul Pharmacol 46: 293-301.
13. Rodriguez-Feo, JA, Hellings, WE, Verhoeven, BA, Moll, FL, de Kleijn, DP, Prendergast, J et al. (2007). Low levels of Nogo-B in human carotid atherosclerotic plaques are associated with an atheromatous phenotype, restenosis, and stenosis severity. Arterioscler Thromb Vasc Biol 27: 1354-1360.
14. Li, Q, Qi, B, Oka, K, Shimakage, M, Yoshioka, N, Inoue, H et al. (2001). Link of a new type of apoptosis-inducing gene ASY/Nogo-B to human cancer. Oncogene 20: 3929-3936.
15. Shimakage, M, Inoue, N, Ohshima, K, Kawahara, K, Oka, T, Yasui, K et al. (2006). Down-regulation of ASY/Nogo transcription associated with progression of adult T-cell leukemia/lymphoma. Int J Cancer 119 1648-1653.
16. Oertle, T, Merkler, D and Schwab, ME (2003). Do cancer cells die because of Nogo-B? Oncogene 22: 1390-1399.
17. Angelini, GD, Bryan, AJ, Williams, HM, Morgan, R and Newby, AC (1990). Distention promotes platelet and leukocyte adhesion and reduces short-term patency in pig arteriovenous bypass grafts. J Thorac Cardiovasc Surg 99: 433-439.
18. Wan, S, George, SJ, Nicklin, SA, Yim, AP and Baker, AH (2004). Overexpression of p53 increases lumen size and blocks neointima formation in porcine interposition vein grafts. Mol Ther 9: 689-698.
19. George, SJ, Lloyd, CT, Angelini, GD, Newby, AC and Baker, AH (2000). Inhibition of late vein graft neointima formation in human and porcine models by adenovirus-mediated overexpression of tissue inhibitor of metalloproteinase-3. Circulation 101: 296-304.
20. Sata, M, Maejima, Y, Adachi, F, Fukino, K, Saiura, A, Sugiura, S et al. (2000). A mouse model of vascular injury that induces rapid onset of medial cell apoptosis followed by reproducible neointimal hyperplasia. J Mol Cell Cardiol 32: 2097-2104.
21. Lindner, V, Fingerle, J and Reidy, MA (1993). Mouse model of arterial injury. Circ Res 73: 792-796.
22. O'Brien, JE Jr., Ormont, ML, Shi, Y, Wang, D, Zalewski, A and Mannion, JD (1998). Early injury to the media after saphenous vein grafting. Ann Thorac Surg 65: 1273-1278.
23. O'Brien, JE Jr., Shi, Y, Fard, A, Bauer, T, Zalewski, A and Mannion, JD (1997). Wound healing around and within saphenous vein bypass grafts. J Thorac Cardiovasc Surg 114: 38-45.
24. Francis, SE, Hunter, S, Holt, CM, Gadsdon, PA, Rogers, S, Duff, GW et al. (1994). Release of platelet-derived growth factor activity from pig venous arterial grafts. J Thorac Cardiovasc Surg 108: 540-548.
25. Miao, RQ, Gao, Y, Harrison, KD, Prendergast, J, Acevedo, LM, Yu, J et al. (2006). Identification of a receptor necessary for Nogo-B stimulated chemotaxis and morphogenesis of endothelial cells. Proc Natl Acad Sci USA 103: 10997-11002.
26. Li, M and Song, J (2007). Nogo-B receptor possesses an intrinsically unstructured ectodomain and a partially folded cytoplasmic domain. Biochem Biophys Res Commun 360: 128-134.
27. Cooney, R, Hynes, SO, Sharif, F, Howard, L and O'Brien, T (2007). Effect of gene delivery of NOS isoforms on intimal hyperplasia and endothelial regeneration after balloon injury. Gene Ther 14: 396-404.
28. Nicklin, SA (1999). Simple methods for preparing recombinant adenoviruses for high-efficiency transduction of vascular cells. In: Baker, AH (ed.). Vascular Disease: Molecular Biology and Gene Therapy Protocols. Humana: Totowa, NJ. pp. 271-283.
29. Southgate, K and Newby, AC (1990). Serum-induced proliferation of rabbit aortic smooth muscle cells from the contractile state is inhibited by 8-Br-cAMP but not 8-Br-cGMP. Atherosclerosis 82: 113-123.
30. George, SJ, Angelini, GD, Capogrossi, MC and Baker, AH (2001). Wild-type p53 gene transfer inhibits neointima formation in human saphenous vein by modulation of smooth muscle cell migration and induction of apoptosis. Gene Ther 8: 668-676.
31. George, SJ, Izzat, MB, Gadsdon, P, Johnson, JL, Yim, AP, Wan, S et al. (2001). Macroporosity is necessary for the reduction of neointimal and medial thickening by external stenting of porcine saphenous vein bypass grafts. Atherosclerosis 155: 329-336.
32. Yu, J, Rudic, RD and Sessa, WC (2002). Nitric oxide-releasing aspirin decreases vascular injury by reducing inflammation and promoting apoptosis. Lab Invest 82: 825-832.